ABSTRACT
Initially, host resistance assays were developed for use in the context of immunosuppression. Such assays include experimental infections and implanted tumours. They have been shown to be useful tools to investigate the global consequences of functional alterations of the immune response due to drug treatment or chemical exposure (Dean et al., 1982; Thomas and Sherwood, 1996).
